Remove Cardiogenic Shock Remove Education Remove Innovation
article thumbnail

FDA Expands Indication for Impella Heart Pumps for Pediatric Patients

DAIC

with SmartAssist and Impella CP with SmartAssist heart pumps, granting premarket approval (PMA) for use in specific pediatric patients with symptomatic acute decompensated heart failure (ADHF) and cardiogenic shock. and Impella CP, both left-sided heart pumps, for pediatric patients with symptomatic ADHF and cardiogenic shock.

article thumbnail

Cardiogenic Shock Teams: Past, Present, and Future Directions

Circulation: Heart Failure

Cardiogenic shock (CS) remains a significant challenge in cardiovascular medicine, characterized by substantial morbidity and mortality. Looking ahead, we propose the extension of CS team models into regional networks, broadening their impact through education, telemedicine and collaborative protocols.

article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

ET Main Tent (Hall B1) Self-expanding Versus Balloon-expandable Transcatheter Aortic Valve Replacement in Patients with Small Aortic Annuli: Primary Outcomes from the Randomized Smart Trial Effect of Edetate Disodium Based Chelation Infusions on Cardiovascular Events in Post-MI Patients with Diabetes: The TACT2 Trial Long-term Beta-blocker Treatment (..)

article thumbnail

American College of Cardiology (ACC24) Show Preview: Advancing Cardiovascular Care for All

DAIC

The American College of Cardiology (ACC) has announced key educational and programming highlights for its ACC 73rd Annual Scientific Session & Expo, ACC.24, We aim to improve global care outcomes through the distribution of educational materials to clinicians in underserved communities worldwide,” Drachman continued.